A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
AO GENERIUM
Huashan Hospital
Aurigene Discovery Technologies Limited
Huabo Biopharm Co., Ltd.
Ewha Womans University Mokdong Hospital
Region of Southern Denmark
Jiangsu Hansoh Pharmaceutical Co., Ltd.
RenJi Hospital
The Affiliated Hospital of Qingdao University
Kineta Inc.
University Health Network, Toronto
Assistance Publique - Hôpitaux de Paris
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Regina Elena Cancer Institute
Cambridge University Hospitals NHS Foundation Trust
Imperial College London
University Hospital, Clermont-Ferrand
Weprom
University of Palermo
Sunnybrook Health Sciences Centre
Helsinki University Central Hospital
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
University Hospital, Strasbourg, France
Centre Hospitalier Universitaire de Besancon
Herlev and Gentofte Hospital
Innersight Labs Ltd
RenJi Hospital
I.M. Sechenov First Moscow State Medical University
I.M. Sechenov First Moscow State Medical University
M.D. Anderson Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
SpeciCare
Herlev and Gentofte Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Junshi Bioscience Co., Ltd.
Sun Yat-sen University
University of Leeds
West China Hospital
University Hospital, Grenoble
Cedars-Sinai Medical Center
University Hospital, Grenoble
M.D. Anderson Cancer Center
Corporacion Parc Tauli
Instituto do Cancer do Estado de São Paulo
Institut Cancerologie de l'Ouest
American College of Radiology Imaging Network
Centre Hospitalier Universitaire de Besancon
University of Sao Paulo
University of Zurich